Featured Insights and Perspectives from Darwin
The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
September 18, 2023
Our Take: J&J to rename Janssen Pharmaceuticals as part of its branding update
Learn More
September 18, 2023
IDN trends, challenges, and leadership
September 25, 2023
Our Take: CommonSpirit launches PHSO to ‘help providers succeed in value-based care’
Learn More
September 25, 2023
Value-based care and alternative payment models
October 2, 2023
IDN trends, challenges, and leadership
October 9, 2023
Our Take: Kaiser Permanente to resume contract negotiations this week as more strikes loom
Learn More
October 9, 2023
IDN trends, challenges, and leadership
October 16, 2023
Our Take: Walgreens to launch virtual care, welcome new CEO as pharmacy staff considers more walkouts
Learn More
October 16, 2023
Pharmacy, PBMs and drug pricing
October 23, 2023
Our Take: Henry Ford Health to form joint venture with Ascension Michigan, Aspirus Health advances affiliation plans with St. Luke’s
Learn More
October 23, 2023
IDN trends, challenges, and leadership
October 30, 2023
Our Take: Feature: Looking ahead, leading drugmakers will focus on innovation within their existing areas of specialty
Learn More
October 30, 2023
Digital health and emerging technologies
.jpg)
November 6, 2023
Our Take: Drugstore chains claim ‘Pharmageddon’ had minimal impact on stores, say they’re listening to workers
Learn More
November 6, 2023
Pharmacy, PBMs and drug pricing
November 13, 2023
Our Take: Lilly scores FDA approval of tirzepatide for weight management, intensifying rivalry with Novo Nordisk
Learn More
November 13, 2023
Pharma strategy, engagement, and market access
November 20, 2023
Our Take: Vertex, CRISPR Therapeutics gain first-ever approval of CRISPR-based gene-edited therapy
Learn More
November 20, 2023
Pharma strategy, engagement, and market access
December 4, 2023
Our Take: AbbVie to acquire ImmunoGen for $10 billion, adding ADC for ovarian cancer to its portfolio
Learn More
December 4, 2023
IDN trends, challenges, and leadership
.jpg)
December 11, 2023
AbbVie announces another multibillion dollar acquisition, while Roche jumps into the GLP-1 rivalry
Learn More
December 11, 2023
IDN trends, challenges, and leadership
Stay Aware. Stay Informed.
Want to stay ahead of health care trends?
Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
